SCHEER – Minutes of the Working Group meeting on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) of 15 January 2020
Posts published in “Breast Implant-Associated Anaplastic Large Cell Lymphoma BIA-ALCL”
Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) – Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL)…
Working Group on safety of breast implants in relation to anaplastic large cell lymphoma (BIA-ALCL) meeting
Australian regulatory action on breast implants and breast tissue expanders
The FDA Takes Action to Protect Patients from Risk of Certain Textured Breast Implants; Requests Allergan Voluntarily Recall Certain Breast Implants and Tissue Expanders from…
In French – The ANSM decides, as a precautionary measure, to withdraw from the market macrotextured breast implants and breast implants with polyurethane-coated surfaces –…
Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
FDA Panel Recommends New Postmarket Requirements for Breast Implants
2019 Meeting Materials of the General and Plastic Surgery Devices Panel
FDA Panel: Too early to pull textured breast implants over cancer risk, need more data